KalVista Pharmaceuticals Appoints Benjamin L. Palleiko as Chief Executive Officer
Company
KalVista Pharmaceuticals
CambridgeBiotechnologyHealth CareresearchDescription
KalVista Pharmaceuticals, Inc. announces the appointment of Benjamin L. Palleiko as Chief Executive Officer and a director of the Company, reflecting the planned transition as the company prepares to become a commercial entity following the success of the KONFIDENT Phase 3 trial for its program sebetralstat.
Quick answer
KalVista Pharmaceuticals Appoints Benjamin L. Palleiko as Chief Executive Officer (March 7, 2024). KalVista Pharmaceuticals is based in Cambridge, Massachusetts, United States.
- What did KalVista Pharmaceuticals announce on March 7, 2024?
- KalVista Pharmaceuticals, Inc. announces the appointment of Benjamin L. Palleiko as Chief Executive Officer and a director of the Company, reflecting the planned transition as the company prepares to become a commercial entity following the success of the KONFIDENT Phase 3 trial for its program sebetralstat.
- What does KalVista Pharmaceuticals do?
- KalVista Pharmaceuticals, Inc. is a pharmaceutical company focused on the discovery, development, and commercialization of oral, small molecule protease inhibitors for diseases with significant unmet need.
- Where is KalVista Pharmaceuticals based?
- KalVista Pharmaceuticals is based in Cambridge, Massachusetts, United States.
- Which similar companies made leadership changes around the same time?
- QuantHealth (February 28, 2024), Arvinas (March 18, 2024), BioAro (February 13, 2024) and Rezolute (January 24, 2024) also announced leadership changes within 45 days of KalVista Pharmaceuticals.
Source: Fundz verified event record.
Other recent leadership changes in research and Biotechnology
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- QuantHealth Appoints Adam Petrich as Chief Medical Officer (February 28, 2024)
- Arvinas Appoints Noah Berkowitz as Chief Medical Officer (March 18, 2024)
- BioAro Welcomes World's First Chief HealthSpan Officer, Raman Kapoor to Lead Precision Health, HealthSpan, and Longevity Initiatives (February 13, 2024)
- Rezolute Expands Leadership Team with Appointment of Daron Evans, MS, MBA, as Chief Financial Officer (January 24, 2024)
- Nusano Names Rohan Jain as Commercial General Manager (January 22, 2024)
- Alkermes appoints Nancy S. Lurker as Independent Director (March 7, 2024)
Who to call at KalVista Pharmaceuticals, and when
A new leader at KalVista Pharmaceuticals brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day KalVista Pharmaceuticals raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at KalVista Pharmaceuticals, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at KalVista Pharmaceuticals. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment KalVista Pharmaceuticals changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
KalVista Pharmaceuticals changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.